Results 171 to 180 of about 315,907 (248)
By integrating single‐cell RNA sequencing and spatial transcriptomics, tenascin C (TNC) is unveiled as a central organizer of the proinflammatory and profibrotic niche in kidney fibrosis. TNC promotes macrophage activation through TLR4/NF‐κB signaling, leading to renal inflammation and fibrosis.
Li Li +14 more
wiley +1 more source
TLR4 rs2149356 Polymorphism in Periodontitis and End-Stage Renal Disease: An Exploratory Analysis in Egyptian Patients. [PDF]
Abou-Bakr A +4 more
europepmc +1 more source
HIFU‐Driven Targeted Pyroptosis Therapy in Basal‐Like Breast Cancer
This study presents a HIFU‐driven pyroptosis strategy for BLBC treatment. Combining HIFU with platelet‐membrane hybridized liposomes encapsulating mitoxantrone enhances tumor targeting and efficacy. The synergistic treatment modulates key epigenetic regulators and activates the pyroptotic pathway through ROS generation and inflammasome signaling ...
Xiaomin Su +13 more
wiley +1 more source
A presentation of brown tumor in a patient with parathyroid adenoma and end-stage renal disease: A case report. [PDF]
Gohar A +7 more
europepmc +1 more source
Prevalence of Elevated Troponin I in End‐stage Renal Disease Patients Receiving Hemodialysis [PDF]
Michael W. Donnino +7 more
openalex +1 more source
Glioblastoma (GBM) is the most aggressive primary brain tumor, with glioma stem cells (GSCs) driving treatment resistance. This study reveals that lactate promotes histone lactylation (H3K18la) at the VRK1 promoter, regulating GSC stemness and proliferation via the H3K18la/VRK1/YBX1/SOX2 pathway. The VRK1‐targeted nanoliposome A/TMZ‐siVRK1 demonstrates
Jinna Li +4 more
wiley +1 more source
Gastrointestinal disease in end-stage renal disease. [PDF]
Khan A +4 more
europepmc +1 more source
GSK461364 Inhibits NLRP3 Inflammasome by Targeting NEK7 Phosphorylation
Schematic diagram of the mechanism by which GSK461364 inhibits NLRP3 inflammasome activation. GSK461364 inhibits the phosphorylation of NEK7 likely at serine 221 and serine 260 by suppressing the activity of PLK1, thereby restraining the formation of the NLRP3 inflammasome.
Ruiheng Luo +13 more
wiley +1 more source
Efficacy and safety of sacubitril/valsartan in end-stage renal disease patients with heart failure: a review. [PDF]
Li P, Li Y, Zhang L.
europepmc +1 more source

